In this study, the clinical factors for predicting PPF were positive non-Jo-1 antibodies, NLR, and serum KL-6, and the cutoff value for NLR and serum KL-6 values that best predicted PPF in patients with ASS-ILD were determined by ROC analysis. Here, MUC1 is linked to interstitial lung disease.